{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:26:47Z","timestamp":1777890407018,"version":"3.51.4"},"reference-count":235,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Gambling disorder or pathological gambling is a psychiatric disorder with severe and wide-ranging consequences for the affected individual and their surroundings. While no pharmacological treatment has yet been officially approved for treatment, various drugs have been investigated to date. An electronic literature search was conducted in PubMed to identify open-label trials, randomized controlled trials, meta-analyses, other reviews and case reports. In addition, the\n                    <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                    registry was reviewed to identify recent advancements, investigational drug candidates, and ongoing or forthcoming clinical research related to this topic. In this review we summarize and compare Fluvoxamine, Paroxetine, Sertraline, Citalopram, Bupropion, Nefazodone, Naltrexone, Nalmefene, Naloxone, Lithium, Valproate, Topiramate, Olanzapine, N-acetylcysteine, Disulfiram, Acamprosate, Memantine, Amantadine, Gabapentinoids, Modafinil, GLP-1 receptor agonists and Ketamine\/Esketamine. From the above-mentioned substances, many have shown promising results in the treatment of gambling disorder, particularly opioid antagonists. However, the small number of studies on the respective drugs, as well as inconsistent designs and contradictory results, limit the significance and clinical applicability of the findings. Here we discuss the most promising drugs, neurobiological pathomechanisms of gambling disorder and potential methodological designs for future studies on this topic.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1806954","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:36:59Z","timestamp":1777613819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Off-label and investigational drugs in the treatment of gambling disorder: a critical review"],"prefix":"10.3389","volume":"17","author":[{"given":"Leon","family":"Bissig","sequence":"first","affiliation":[{"name":"Psychiatric Services Lucerne","place":["Lucerne, Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Mutschler","sequence":"additional","affiliation":[{"name":"Psychiatric Services Lucerne","place":["Lucerne, Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1530-0277.1998.tb03872.x","article-title":"Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex","volume":"22","author":"Al Qatari","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacological Sciences"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107127","DOI":"10.1016\/j.addbeh.2021.107127","article-title":"Intranasal as needed naloxone in the treatment of gambling disorder: a randomised controlled trial","volume":"125","author":"Alho","year":"2022","journal-title":"Addict. Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fncel.2020.00083","article-title":"Pregabalin as a pain therapeutic: beyond calcium channels","volume":"14","author":"Alles","year":"2020","journal-title":"Front. Cellular Neuroscience"},{"key":"B5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/npp.2010.226","article-title":"Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans","volume":"36","author":"Amen","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.genhosppsych.2008.02.002","article-title":"Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review","volume":"30","author":"Arbaizar","year":"2008","journal-title":"General Hosp. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of topiramate for treatment of psychiatric disorders","volume":"4","author":"Arnone","year":"2005","journal-title":"Ann. General Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1185\/03007995.2010.515900","article-title":"Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives","volume":"26","author":"Ascher-Svanum","year":"2010","journal-title":"Curr. Medical Research Opinion"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jad.2024.11.019","article-title":"A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: target engagement and rationale for the development in mental disorders","volume":"370","author":"Au","year":"2025","journal-title":"J. Affective Disorders"},{"key":"B10","first-page":"246","article-title":"The mechanism of action of amantadine in parkinsonism: a review","volume":"216","author":"Bailey","year":"1975","journal-title":"Archives Int. de pharmacodynamie de Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/npp.2009.233","article-title":"Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats","volume":"35","author":"Bari","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/a:1023057027992","article-title":"Alcohol consumption and self-control of gambling behaviour","volume":"15","author":"Baron","year":"1999","journal-title":"J. Gambl. Stud."},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.13202","article-title":"When and how to use lithium","volume":"142","author":"Barroilhet","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11469-006-9022-z","article-title":"Suicide ideation and behaviour in people with pathological gambling attending a treatment service","volume":"4","author":"Battersby","year":"2006","journal-title":"Int. Journal Mental Health Addiction"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1023\/a:1021223113233","article-title":"Risky business: emotion, decision-making, and addiction","volume":"19","author":"Bechara","year":"2003","journal-title":"J. Gambling Studies"},{"key":"B17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S1474-4422(16)00066-1","article-title":"Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and hawthorne effects","volume":"15","author":"Benedetti","year":"2016","journal-title":"Lancet Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"19","author":"Benmansour","year":"1999","journal-title":"J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02104968","article-title":"Social, psychological and physical consequences of pathological gambling in Sweden","volume":"10","author":"Bergh","year":"1994","journal-title":"J. Gambling Studies"},{"key":"B20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1017\/s0033291796003789","article-title":"Altered dopamine function in pathological gambling","volume":"27","author":"Bergh","year":"1997","journal-title":"Psychol. Medicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/15622975.2011.560964","article-title":"A double-blind, placebo-controlled trial of topiramate for pathological gambling","volume":"14","author":"Berlin","year":"2013","journal-title":"World Journal Biological Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathologic gambling","volume":"24","author":"Black","year":"2004","journal-title":"J. Clinical Psychopharmacology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","article-title":"Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study","volume":"27","author":"Black","year":"2007","journal-title":"J. Clinical Psychopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.31887\/DCNS.2010.12.2\/dblack","article-title":"Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum?","volume":"12","author":"Black","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/104012371102300403","article-title":"An open-label trial of acamprosate in the treatment of pathological gambling","volume":"23","author":"Black","year":"2011","journal-title":"Ann. Clin. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/jcm13072154","article-title":"An international, multidisciplinary consensus set of patient-centered outcome measures for substance-related and addictive disorders","volume":"13","author":"Black","year":"2024","journal-title":"J. Clinical Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/a:1015215809770","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling","volume":"14","author":"Blanco","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2466\/pr0.1999.84.1.107","article-title":"Pathological gambling and obsessive-compulsive spectrum disorders","volume":"84","author":"Blaszczynski","year":"1999","journal-title":"Psychol. Reports"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.06.032","article-title":"The interaction of person-affect-cognition-execution (I-PACE) model for addictive behaviors: update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors","volume":"104","author":"Brand","year":"2019","journal-title":"Neurosci. and Biobehav. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JRS-2004-292","article-title":"Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): a review and analysis","volume":"16","author":"Breggin","year":"2004","journal-title":"Int. J. Risk and Saf. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/2045125312471963","article-title":"Lithium: the pharmacodynamic actions of the amazing ion","volume":"3","author":"Brown","year":"2013","journal-title":"Ther. Advances Psychopharmacology"},{"key":"B32","volume-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2012"},{"key":"B33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Carmen","year":"2004","journal-title":"Addiction"},{"key":"B34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1600-0447.1994.tb01619.x","article-title":"Low platelet monoamine oxidase activity in pathological gambling","volume":"90","author":"Carrasco","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1441815","DOI":"10.3389\/fpsyt.2024.1441815","article-title":"Trend-analysis reveals real and placebo rtms effects on addiction craving: a case-control observational study","volume":"15","author":"Casula","year":"2025","journal-title":"Front. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-psych-040725-025923","article-title":"The impaired response inhibition and salience attribution model of drug addiction: recent neuroimaging evidence and future directions","volume":"77","author":"Ceceli","year":"2025","journal-title":"Annu. Rev. Psychol."},{"key":"B37","volume-title":"Incorporating alcohol pharmacotherapies Into medical practice: a review of the literature","year":"2009"},{"key":"B38","article-title":"Lithium","volume-title":"StatPearls","author":"Chokhawala","year":"2025"},{"key":"B39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41380-018-0230-2","article-title":"Neuroimaging of reward mechanisms in gambling disorder: an integrative review","volume":"24","author":"Clark","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41386-020-00911-5","article-title":"Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders","volume":"46","author":"Cohen","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"CD008937","DOI":"10.1002\/14651858.CD008937.pub2","article-title":"Psychological therapies for pathological and problem gambling","volume":"2012","author":"Cowlishaw","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B42","volume-title":"Pregabalin","author":"Cross","year":"2025"},{"key":"B43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/mpr.273","article-title":"Towards DSM\u2010V: considering other withdrawal\u2010like symptoms of pathological gambling disorder","volume":"18","author":"Cunningham\u2010Williams","year":"2009","journal-title":"Int. Journal Methods Psychiatric Research"},{"key":"B44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10899-013-9360-2","article-title":"Citalopram-associated gambling: a case report","volume":"30","author":"Cuomo","year":"2014","journal-title":"J. Gambling Studies"},{"key":"B45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study","volume":"28","author":"Dannon","year":"","journal-title":"Clin. Neuropharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study","volume":"25","author":"Dannon","year":"","journal-title":"J. Clinical Psychopharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/jcp.0b013e31815a4400","article-title":"12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study","volume":"27","author":"Dannon","year":"2007","journal-title":"J. Clinical Psychopharmacology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fpsyt.2011.00033","article-title":"Acamprosate and baclofen were not effective in the treatment of pathological gambling: preliminary blind rater comparison study","volume":"2","author":"Dannon","year":"2011","journal-title":"Front. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2165\/00003495-199753040-00006","article-title":"Nefazodone: a review of its pharmacology and clinical efficacy in the management of major depression","volume":"53","author":"Davis","year":"1997","journal-title":"Drugs"},{"key":"B51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.14744\/DAJPNS.2019.00053","article-title":"Pathological gambling in a patient with Parkinson's disease and valproate response","volume":"32","author":"Degirmenci","year":"2019","journal-title":"Dusunen Adam"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4088\/JCP.08m04359","article-title":"A cross-sectional study of problem and pathological gambling in patients with schizophrenia\/schizoaffective disorder","volume":"70","author":"Desai","year":"2009","journal-title":"J. Clinical Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00213-017-4744-0","article-title":"Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels","volume":"235","author":"Di Ciano","year":"2018","journal-title":"Psychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jad.2014.06.023","article-title":"Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment","volume":"167","author":"Di Nicola","year":"2014","journal-title":"J. Affect. Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/j.1552-4604.1987.tb02191.x","article-title":"Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist","volume":"27","author":"Dixon","year":"1987","journal-title":"J. Clin. Pharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"CD008936","DOI":"10.1002\/14651858.CD008936.pub2","article-title":"Pharmacological interventions for the treatment of disordered and problem gambling","volume":"2022","author":"Dowling","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2466\/pr0.103.2.485-498","article-title":"A meta-analysis examining the relations among pathological gambling, obsessive-compulsive disorder, and obsessive-compulsive traits","volume":"103","author":"Durdle","year":"2008","journal-title":"Psychol. Reports"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e69010","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnins.2019.00160","article-title":"Does sex\/gender play a role in placebo and nocebo effects? Conflicting evidence from clinical trials and experimental studies","volume":"13","author":"Enck","year":"","journal-title":"Front. Neuroscience"},{"key":"B60","first-page":"399","article-title":"Placebos and the placebo effect in drug trials","volume-title":"Concepts and principles of pharmacology: 100 years of the handbook of experimental pharmacology","author":"Enck","year":""},{"key":"B61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ncpgasthep0237","article-title":"Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome","volume":"2","author":"Enck","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterology and Hepatology"},{"key":"B62","article-title":"N-Acetylcysteine","volume-title":"StatPearls","author":"Ershad","year":"2025"},{"key":"B63","doi-asserted-by":"publisher","first-page":"106503","DOI":"10.1016\/j.cct.2021.106503","article-title":"What can be done to control the placebo response in clinical trials? A narrative review","volume":"107","author":"Evans","year":"2021","journal-title":"Contemp. Clinical Trials"},{"key":"B64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.01.017","article-title":"Ketamine for the treatment of addiction: evidence and potential mechanisms","volume":"142","author":"Ezquerra-Romano","year":"2018","journal-title":"Neuropharmacology"},{"key":"B66","volume-title":"Topiramate","author":"Fariba","year":"2025"},{"key":"B67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jamapsychiatry.2025.4308","article-title":"Prospects of GLP-1 therapies for addiction and mental health comorbidities\u2014Quo Vadis?: a review","volume":"83","author":"Farokhnia","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","article-title":"A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers","volume":"89","author":"Fong","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10899-022-10180-0","article-title":"Prevalence of problem gambling: a meta-analysis of recent empirical research (2016\u20132022)","volume":"39","author":"Gabellini","year":"2023","journal-title":"J. Gambl. Stud."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/j.eurpsy.2025.10122","article-title":"Psychiatric morbidity and gambling disorder: a systematic review and meta-analysis of population-based surveys","volume":"68","author":"Galeazzi","year":"2025","journal-title":"Eur. Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamapsychiatry.2016.2157","article-title":"Association of the sweet-liking phenotype and craving for alcohol with the response to naltrexone treatment in alcohol dependence: a randomized clinical trial","volume":"73","author":"Garbutt","year":"2016","journal-title":"Jama Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/02698811241254834","article-title":"Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems","volume":"38","author":"Gent","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.14l01707","article-title":"New onset of compulsive gambling associated with modafinil: a case report","volume":"17","author":"George","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention\u2013based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4088\/jcp.v62n1207","article-title":"Demographic and clinical features of 131 adult pathological gamblers","volume":"62","author":"Grant","year":"2001","journal-title":"J. Clinical Psychiatry"},{"key":"B76","first-page":"143","article-title":"Pathological gambling and alcohol use disorder","volume":"26","author":"Grant","year":"2002","journal-title":"Alcohol Res. and Health"},{"key":"B77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00004850-200307000-00007","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial","volume":"18","author":"Grant","year":"2003","journal-title":"Int. Clinical Psychopharmacology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4088\/jcp.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"","journal-title":"J. Clin. Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","article-title":"Predicting response to opiate antagonists and placebo in the treatment of pathological gambling","volume":"200","author":"Grant","year":"","journal-title":"Psychopharmacology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","article-title":"Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study","volume":"197","author":"Grant","year":"","journal-title":"Br. J. Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","article-title":"Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study","volume":"212","author":"Grant","year":"","journal-title":"Psychopharmacology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.4088\/JCP.16m11220","article-title":"Naltrexone and disulfiram treatment response in veterans with alcohol dependence and co-occurring problem-gambling features","volume":"78","author":"Grant","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jpsychires.2024.11.006","article-title":"Defining treatment response in gambling disorder","volume":"180","author":"Grant","year":"2024","journal-title":"J. Psychiatric Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","article-title":"A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence","volume":"23","author":"Gual","year":"2013","journal-title":"Eur. Neuropsychopharmacology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/01.ALC.0000030561.15921.A9","article-title":"A double\u2010blind, placebo\u2010controlled study of naltrexone in the treatment of alcohol\u2010dependence disorder: results from a multicenter clinical trial","volume":"26","author":"Guardia","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40263-015-0244-0","article-title":"Topiramate in alcohol use disorders: review and update","volume":"29","author":"Guglielmo","year":"2015","journal-title":"CNS Drugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3758\/s13415-018-00662-3","article-title":"Cued for risk: evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior","volume":"19","author":"Hellberg","year":"2019","journal-title":"Cognitive, Affect. and Behav. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/02791072.1988.10472494","article-title":"Pharmacological adjuncts in the treatment of opioid and cocaine addicts","volume":"20","author":"Herridge","year":"1988","journal-title":"J. Psychoactive Drugs"},{"key":"B92","doi-asserted-by":"publisher","first-page":"114892","DOI":"10.1016\/j.bcp.2021.114892","article-title":"Mechanisms of ketamine and its metabolites as antidepressants","volume":"197","author":"Hess","year":"2022","journal-title":"Biochem. Pharmacology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","article-title":"Gambling disorders","volume":"378","author":"Hodgins","year":"2011","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","article-title":"Short-term single-blind fluvoxamine treatment of pathological gambling","volume":"155","author":"Hollander","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathologic gambling","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4088\/jcp.v62n0311","article-title":"A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder","volume":"62","author":"Hollander","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10899-004-1932-8","article-title":"Pharmacological treatments of pathological gambling","volume":"21","author":"Hollander","year":"","journal-title":"J. Gambling Studies"},{"key":"B98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"","journal-title":"Am. J. Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e013433","DOI":"10.1136\/bmjopen-2016-013433","article-title":"Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis","volume":"7","author":"Houghton","year":"2017","journal-title":"BMJ Open"},{"key":"B100","volume-title":"Bupropion","author":"Huecker","year":"2017"},{"key":"B101","article-title":"Bupropion","volume-title":"StatPearls","author":"Huecker","year":"2025"},{"key":"B102","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.addbeh.2019.01.024","article-title":"Alcohol use, psychiatric disorders and gambling behaviors: a multi-sample study testing causal relationships via the co-twin control design","volume":"93","author":"Huggett","year":"2019","journal-title":"Addict. Behaviors"},{"key":"B103","doi-asserted-by":"publisher","first-page":"152566","DOI":"10.1016\/j.comppsych.2024.152566","article-title":"Pharmacological management of gambling disorder: a systematic review and network meta-analysis","volume":"137","author":"Ioannidis","year":"2025","journal-title":"Compr. Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6","author":"Jensen","year":"2002","journal-title":"Eur. J. Pain"},{"key":"B105","article-title":"Psilocybin-augmented psychotherapy for gambling disorder: protocol for A double-blind randomized controlled trial","volume-title":"CSAM-SMCA 2024 Scientific Conference","author":"J\u00e9r\u00e9mie Richard","year":"2024"},{"key":"B106","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/10503300601158822","article-title":"Cognitive\u2013behavioral group treatment for pathological gambling: analysis of effectiveness and predictors of therapy outcome","volume":"17","author":"Jim\u00e9nez-Murcia","year":"2007","journal-title":"Psychotherapy Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fpsyg.2016.00465","article-title":"Treatment outcome in male gambling disorder patients associated with alcohol use","volume":"7","author":"Jim\u00e9nez-Murcia","year":"2016","journal-title":"Front. Psychology"},{"key":"B108","article-title":"MD, mental health issues: alcohol use disorder and common Co-occurring conditions","author":"Jo\u00e3o","year":"2025","journal-title":"NIAAA Core Resour. Alcohol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opinion Pharmacology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1192\/bjp.bp.114.154286","article-title":"Gambling problems in bipolar disorder in the UK: prevalence and distribution","volume":"207","author":"Jones","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"B111","volume-title":"Naloxone","author":"Jordan","year":"2025"},{"key":"B112","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Reviews Neuroscience"},{"key":"B113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Dependence"},{"key":"B114","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S2215-0366(23)00026-3","article-title":"Effects of repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex on symptom domains in neuropsychiatric disorders: a systematic review and cross-diagnostic meta-analysis","volume":"10","author":"Kan","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4088\/jcp.v59n1206","article-title":"Divalproex sodium for impulsive aggressive behavior in patients with personality disorder","volume":"59","author":"Kavoussi","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"B116","first-page":"3","article-title":"Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications","volume":"63","author":"Keck","year":"2002","journal-title":"J. Clinical Psychiatry"},{"key":"B117","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12019-003-0007-6","article-title":"The antidepressant sertraline: a review of its uses in a range of psychiatric and medical conditions","volume":"29","author":"Khouzam","year":"2003","journal-title":"Compr. Therapy"},{"key":"B118","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder","volume":"16","author":"Kim","year":"2001","journal-title":"Int. Clinical Psychopharmacology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/s0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"B120","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4088\/jcp.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling","volume":"63","author":"Kim","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B121","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eurpsy.2018.11.001","article-title":"Updated European consensus statement on diagnosis and treatment of adult ADHD","volume":"56","author":"Kooij","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"B122","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000435876","article-title":"A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling","volume":"22","author":"Kovanen","year":"2016","journal-title":"Eur. Addiction Research"},{"key":"B123","doi-asserted-by":"publisher","first-page":"i93","DOI":"10.1093\/ijnp\/pyae059.161","article-title":"Exploring the neurobiological and psychological mechanisms of ketamine in problematic gambling: a mechanistic study","volume":"28","author":"Kreck\u00e9","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"112581","DOI":"10.1016\/j.drugalcdep.2025.112581","article-title":"High stakes: associations between substance use and gambling behaviors by race in the United States","volume":"268","author":"Kresovich","year":"2025","journal-title":"Drug Alcohol Dependence"},{"key":"B125","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1037\/bul0000411","article-title":"Suicidality among individuals with gambling problems: a meta-analytic literature review","volume":"150","author":"Kristensen","year":"2024","journal-title":"Psychol. Bulletin"},{"key":"B126","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1530-0277.2007.00344.x","article-title":"Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam","volume":"31","author":"Krupitsky","year":"2007","journal-title":"Alcohol. Clin. Experimental Research"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2165\/00003495-200868130-00003","article-title":"Approved and investigational uses of modafinil: an evidence-based review","volume":"68","author":"Kumar","year":"2008","journal-title":"Drugs"},{"key":"B129","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF02104905","article-title":"Social cost of pathological gambling","volume":"10","author":"Ladouceur","year":"1994","journal-title":"J. Gambling Studies"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","article-title":"Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1360-0443.1991.tb01863.x","article-title":"Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse and pathological gambling treatment unit using the addiction severity index","volume":"86","author":"Lesieur","year":"1991","journal-title":"Br. Journal Addiction"},{"key":"B132","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tins.2023.12.004","article-title":"An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions","volume":"47","author":"Lewis","year":"2024","journal-title":"Trends Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"109802","DOI":"10.1016\/j.pnpbp.2019.109802","article-title":"The anticipatory dopamine response in addiction: a common neurobiological underpinning of gambling disorder and substance use disorder?","volume":"98","author":"Linnet","year":"2020","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.addbeh.2015.02.021","article-title":"Personality traits of problem gamblers with and without alcohol dependence","volume":"47","author":"Lister","year":"2015","journal-title":"Addict. Behav."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/mp.2014.113","article-title":"Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models","volume":"20","author":"Lobo","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"B136","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1556\/2006.8.2019.64","article-title":"A systematic review of gambling-related findings from the national epidemiologic survey on alcohol and related conditions","volume":"8","author":"Loo","year":"2019","journal-title":"J. Behav. Addict."},{"key":"B137","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1360-0443.2010.03300.x","article-title":"Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta\u2010analysis of population surveys","volume":"106","author":"Lorains","year":"2011","journal-title":"Addiction"},{"key":"B138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/1520-6629(198301)11:1<67::aid-jcop2290110107>3.0.co;2-o","article-title":"The impact of pathological gambling on the spouse of the gambler","volume":"11","author":"Lorenz","year":"1983","journal-title":"J. Community Psychol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"13968","DOI":"10.1523\/JNEUROSCI.2808-07.2007","article-title":"Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine","volume":"27","author":"Madayag","year":"2007","journal-title":"J. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta\u2010analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"B142","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1556\/2006.2022.00080","article-title":"Craving in gambling disorder: a systematic review","volume":"12","author":"Mallorqu\u00ed-Bagu\u00e9","year":"2023","journal-title":"J. Behav. Addict."},{"key":"B143","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","article-title":"Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene","volume":"73","author":"Mann","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B144","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/1874473710801020213","article-title":"Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies","volume":"1","author":"Mart\u00ednez-Raga","year":"2008","journal-title":"Curr. Drug Abuse Reviews"},{"key":"B145","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1360-0443.2009.02792.x","article-title":"Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi\u2010centre, randomized, single\u2010blind comparison trial","volume":"105","author":"Martinotti","year":"2010","journal-title":"Addiction"},{"key":"B146","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J. Neuroscience"},{"key":"B148","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0010-440x(96)90001-2","article-title":"Are impulse-control disorders related to bipolar disorder?","volume":"37","author":"McElroy","year":"1996","journal-title":"Compr. Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4088\/jcp.v69n0314","article-title":"Olanzapine in the, treatment of pathological gambling: a negative randomized placebo-controlled trial","volume":"69","author":"McElroy","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jad.2006.12.005","article-title":"Problem gambling in bipolar disorder: results from the Canadian community health survey","volume":"102","author":"McIntyre","year":"2007","journal-title":"J. Affective Disorders"},{"key":"B151","doi-asserted-by":"publisher","first-page":"eadr5051","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci. Adv."},{"key":"B152","doi-asserted-by":"publisher","first-page":"106163","DOI":"10.1016\/j.neubiorev.2025.106163","article-title":"Efficacy and safety of psilocybin for the treatment of substance use disorders: a systematic review","volume":"173","author":"Meshkat","year":"2025","journal-title":"Neurosci. and Biobehav. Rev."},{"key":"B153","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1523\/JNEUROSCI.0115-14.2014","article-title":"Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA\/kainate signaling","volume":"34","author":"Mietlicki-Baase","year":"2014","journal-title":"J. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pbb.2013.11.013","article-title":"The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models","volume":"116","author":"Moore","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"B157","doi-asserted-by":"publisher","first-page":"107968","DOI":"10.1016\/j.addbeh.2024.107968","article-title":"Association between endocrine and neuropsychological endophenotypes and gambling disorder severity","volume":"153","author":"Mora-Maltas","year":"2024","journal-title":"Addict. Behaviors"},{"key":"B158","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1523\/JNEUROSCI.1459-22.2022","article-title":"D2\/3 agonist during learning potentiates cued risky choice","volume":"43","author":"Mortazavi","year":"2023","journal-title":"J. Neurosci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0031-1271683","article-title":"Treatment of pathological gambling with disulfiram: a report of 2 cases","volume":"44","author":"M\u00fcller","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"B160","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/add.15572","article-title":"Effect of extended\u2010release naltrexone on alcohol consumption: a systematic review and meta\u2010analysis","volume":"117","author":"Murphy IV","year":"2022","journal-title":"Addiction"},{"key":"B161","doi-asserted-by":"publisher","first-page":"A110","DOI":"10.1055\/s-0029-1240182","article-title":"Disulfiram in the treatment of pathological gambling?","volume":"42","author":"Mutschler","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"B162","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mehy.2009.07.007","article-title":"Disulfiram, an old drug with new potential in the treatment of pathological gambling?","volume":"74","author":"Mutschler","year":"","journal-title":"Med. Hypotheses"},{"key":"B163","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/alcalc\/agp093","article-title":"Disulfiram, an option for the treatment of pathological gambling?","volume":"45","author":"Mutschler","year":"","journal-title":"Alcohol and Alcohol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/biom9050191","article-title":"Amantadine combines astroglial system xc\u2212 activation with glutamate\/nmda receptor inhibition","volume":"9","author":"Nakano","year":"2019","journal-title":"Biomolecules"},{"key":"B55","volume-title":"LiverTox: clinical and research information on drug-induced liver injury [Internet]","year":"2012"},{"key":"B165","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.02.012","article-title":"\u03ba-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats","volume":"61","author":"Nealey","year":"2011","journal-title":"Neuropharmacology"},{"key":"B166","volume-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2012"},{"key":"B167","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/00048670701400040","article-title":"Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder","volume":"41","author":"Nicolato","year":"2007","journal-title":"Aust. NZJ Psychiatry"},{"key":"B168","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1017\/s1092852900006799","article-title":"Altered CSF 5-HIAA disposition in pathologic male gamblers","volume":"4","author":"Nordin","year":"1999","journal-title":"CNS Spectrums"},{"key":"B169","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00213-011-2496-9","article-title":"Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats","volume":"219","author":"Ohmura","year":"2012","journal-title":"Psychopharmacology"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1530-0277.2008.00682.x","article-title":"Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non\u2010natives residing in rural settings: a randomized controlled trial","volume":"32","author":"O\u2019Malley","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"B171","first-page":"239","article-title":"Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille","year":"1995","journal-title":"Alcohol Alcohol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/08897077.2019.1635962","article-title":"The use of off-label medications in substance abuse treatment programs","volume":"41","author":"Paino","year":"2020","journal-title":"Subst. Abuse"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4088\/jcp.v63n1114","article-title":"Nefazodone treatment of pathological gambling: a prospective open-label controlled trial","volume":"63","author":"Pallanti","year":"","journal-title":"J. Clin. Psychiatry"},{"key":"B174","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4088\/jcp.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: a randomized single-blind study","volume":"63","author":"Pallanti","year":"","journal-title":"J. Clin. Psychiatry"},{"key":"B175","doi-asserted-by":"publisher","first-page":"E42","DOI":"10.1176\/jnp.23.3.jnpe42","article-title":"Psychopharmacological treatment of obsessive-compulsive disorder comorbid with body dysmorphic disorder and pathological gambling disorder","volume":"23","author":"Pavlovic","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone\u2010maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"B177","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4088\/jcp.v66n0504","article-title":"Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"66","author":"Petry","year":"2005","journal-title":"J. Clinical Psychiatry"},{"key":"B178","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/01.jcp.0000245566.52401.20","article-title":"The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking","volume":"26","author":"Pettinati","year":"2006","journal-title":"J. Clinical Psychopharmacology"},{"key":"B179","doi-asserted-by":"publisher","first-page":"109786","DOI":"10.1155\/2014\/109786","article-title":"Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives","volume":"2014","author":"Pettorruso","year":"2014","journal-title":"BioMed Res. Int."},{"key":"B180","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fpsyt.2012.00102","article-title":"Amantadine in the treatment of pathological gambling: a case report","volume":"3","author":"Pettorruso","year":"2012","journal-title":"Front. Psychiatry"},{"key":"B181","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0924-9338(13)77453-4","article-title":"2876\u2013Glutamatergic strategies in the treatment of pathological gambling: a pilot study","volume":"28","author":"Pettorruso","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"B182","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neubiorev.2020.09.034","article-title":"Exploring dopaminergic transmission in gambling addiction: a systematic translational review","volume":"119","author":"Pettorruso","year":"2020","journal-title":"Neurosci. and Biobehav. Rev."},{"key":"B183","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1098\/rstb.2008.0100","article-title":"The neurobiology of pathological gambling and drug addiction: an overview and new findings","volume":"363","author":"Potenza","year":"2008","journal-title":"Philosophical Trans. R. Soc. B Biol. Sci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.conb.2013.03.004","article-title":"Neurobiology of gambling behaviors","volume":"23","author":"Potenza","year":"2013","journal-title":"Curr. Opinion Neurobiology"},{"key":"B185","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/appi.ajp.158.3.497-a","article-title":"Schizophrenia and pathological gambling","volume":"158","author":"Potenza","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"B186","article-title":"Valproic acid","volume-title":"StatPearls","author":"Rahman","year":"2025"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Archives General Psychiatry"},{"key":"B188","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11914-022-00750-x","article-title":"Effects of gabapentin and pregabalin on calcium homeostasis: implications for physical rehabilitation of musculoskeletal tissues","volume":"20","author":"Reyes Fernandez","year":"2022","journal-title":"Curr. Osteoporosis Reports"},{"key":"B189","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1556\/2006.2024.00004","article-title":"Psychedelic-assisted therapy for people with gambling disorder?","volume":"13","author":"Romero","year":"2024","journal-title":"J. Behavioral Addictions"},{"key":"B190","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addbeh.2017.05.032","article-title":"Current suicidal ideation in treatment-seeking individuals in the United Kingdom with gambling problems","volume":"74","author":"Ronzitti","year":"2017","journal-title":"Addict. Behaviors"},{"key":"B191","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00005053-199302000-00006","article-title":"Neuropsychological assessment of attention problems in pathological gamblers","volume":"181","author":"Rugle","year":"1993","journal-title":"J. Nervous Mental Disease"},{"key":"B192","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4088\/jcp.v66n0104","article-title":"Sertraline treatment of pathological gambling: a pilot study","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"B193","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","article-title":"Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence","volume":"53","author":"Sass","year":"1996","journal-title":"Archives General Psychiatry"},{"key":"B194","first-page":"1722","article-title":"Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: a meta\u2010regression analysis to develop an enrichment strategy","volume-title":"Alcohol. Clin. Exp. Res.","author":"Scherrer","year":"2021"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e25790","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"PloS One"},{"key":"B196","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1570159033477107","article-title":"Cellular actions of gabapentin and related compounds on cultured sensory neurones","volume":"1","author":"Scott","year":"2003","journal-title":"Curr. Neuropharmacol."},{"key":"B197","first-page":"32","article-title":"Bupropion sustained release: side effect profile","volume":"59","author":"Settle","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"B198","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1017\/s1092852900021416","article-title":"The effect of pathological gambling on families, marriages, and children","volume":"12","author":"Shaw","year":"2007","journal-title":"CNS Spectrums"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1176\/ajp.133.12.1409","article-title":"The effect of lithium on impulsive aggressive behavior in man","volume":"133","author":"Sheard","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"B200","doi-asserted-by":"publisher","first-page":"70","DOI":"10.13078\/jsm.230011","article-title":"Pathological gambling disorder associated with modafinil therapy in a patient with type 1 narcolepsy","volume":"20","author":"Shin","year":"2023","journal-title":"J. Sleep Medicine"},{"key":"B201","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1176\/appi.ajp.163.2.297","article-title":"Natural recovery and treatment-seeking in pathological gambling: results of two US national surveys","volume":"163","author":"Slutske","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B202","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/thg.2013.11","article-title":"Shared genetic vulnerability for disordered gambling and alcohol use disorder in men and women: evidence from a national community-based Australian Twin study","volume":"16","author":"Slutske","year":"2013","journal-title":"Twin Res. Hum. Genet."},{"key":"B203","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuropharm.2013.05.015","article-title":"Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers","volume":"73","author":"Smart","year":"2013","journal-title":"Neuropharmacology"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s10899-023-10235-w","article-title":"Associations between heavy episodic drinking, drinking while gambling, and risky gambling","volume":"39","author":"Smit","year":"2023","journal-title":"J. Gambl. Stud."},{"key":"B205","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1038\/s41598-022-10391-w","article-title":"The role of neurotrophin genes involved in the vulnerability to gambling disorder","volume":"12","author":"Sol\u00e9-Morata","year":"2022","journal-title":"Sci. Rep."},{"key":"B206","doi-asserted-by":"publisher","first-page":"CD001765","DOI":"10.1002\/14651858.CD001765.pub3","article-title":"Selective serotonin re\u2010uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)","volume":"2008","author":"Soomro","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"B207","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-0035-1565184","article-title":"Comparing nalmefene and naltrexone in alcohol dependence: are there any differences? Results from an indirect meta-analysis","volume":"55","author":"Soyka","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"B208","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/10401239509149623","article-title":"Impulse control disorders and attention deficit disorder in pathological gamblers","volume":"7","author":"Specker","year":"1995","journal-title":"Ann. Clin. Psychiatry"},{"key":"B209","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0303-8467(92)90006-o","article-title":"Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?","volume":"94","author":"Stoof","year":"1992","journal-title":"Clin. Neurology Neurosurgery"},{"key":"B210","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-015-0512-x","article-title":"Naltrexone: not just for opioids anymore","volume":"12","author":"Sudakin","year":"2016","journal-title":"J. Med. Toxicol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/1087054715626512","article-title":"Exploring the relationships between problem gambling and ADHD: a meta-analysis","volume":"23","author":"Theule","year":"2019","journal-title":"J. Attention Disorders"},{"key":"B212","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann. Neurology"},{"key":"B213","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00213-019-05376-z","article-title":"The effects of alcohol on sequential decision-making biases during gambling","volume":"237","author":"Tobias-Webb","year":"2020","journal-title":"Psychopharmacology"},{"key":"B214","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Archives General Psychiatry"},{"key":"B216","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10550490902787007","article-title":"A randomized, double\u2010blind, placebo\u2010controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling","volume":"18","author":"Toneatto","year":"2009","journal-title":"Am. J. Addict."},{"key":"B217","doi-asserted-by":"publisher","first-page":"E594","DOI":"10.1016\/S2468-2667(24)00126-9","article-title":"The prevalence of gambling and problematic gambling: a systematic review and meta-analysis","volume":"9","author":"Tran","year":"2024","journal-title":"Lancet Public Health"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2147\/JPR.S134745","article-title":"A systematic review of sex differences in the placebo and the nocebo effect","volume":"10","author":"Vambheim","year":"2017","journal-title":"J. Pain Research"},{"key":"B219","doi-asserted-by":"publisher","first-page":"e30909","DOI":"10.1371\/journal.pone.0030909","article-title":"Response inhibition during cue reactivity in problem gamblers: an fMRI study","volume":"7","author":"Van Holst","year":"2012","journal-title":"Plos One"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/s0924-9338(11)72995-9","article-title":"P03-121-Valproate and cognitive therapy combined treatment efficacy in pathological gambling","volume":"26","author":"Vasile","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1702448","DOI":"10.3389\/fphar.2025.1702448","article-title":"The potential role of GLP-1 receptor agonists in substance use disorders\u2013a systematic review","volume":"16","author":"V\u00f6lker","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B223","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurology"},{"key":"B224","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10899-015-9564-8","article-title":"The relationship between problem gambling and attention deficit hyperactivity disorder","volume":"32","author":"Waluk","year":"2016","journal-title":"J. Gambl. Stud."},{"key":"B225","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1556\/2006.7.2018.89","article-title":"The use of naltrexone in pathological and problem gambling: a UK case series","volume":"7","author":"Ward","year":"2018","journal-title":"J. Behavioral Addictions"},{"key":"B226","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross\u2010sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann. Neurology"},{"key":"B227","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1176\/appi.ajp.158.2.282","article-title":"A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults","volume":"158","author":"Wilens","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"B228","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0002-9343(90)90534-k","article-title":"Disulfiram treatment of alcoholism","volume":"88","author":"Wright","year":"1990","journal-title":"Am. Journal Medicine"},{"key":"B229","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1556\/2006.2023.00026","article-title":"Longitudinal associations between psychiatric comorbidity and the severity of gambling disorder: results from a 36-month follow-up study of clients in Bavarian outpatient addiction care","volume":"12","author":"Wullinger","year":"2023","journal-title":"J. Behav. Addict."},{"key":"B230","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/mp.2017.239","article-title":"Ketamine and its metabolite (2R, 6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","volume":"23","author":"Yao","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B231","article-title":"Gabapentin","volume-title":"StatPearls","author":"Yasaei","year":"2025"},{"key":"B232","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.npp.1300333","article-title":"Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers","volume":"29","author":"Zack","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B233","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/0269881108091072","article-title":"Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity","volume":"23","author":"Zack","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/157340012798994911","article-title":"The neuropsychopharmacology of pathological gambling","volume":"8","author":"Zakeri","year":"2012","journal-title":"Curr. Psychiatry Reviews"},{"key":"B235","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4088\/jcp.v63n0109","article-title":"An open-label study of citalopram in the treatment of pathological gambling","volume":"63","author":"Zimmerman","year":"2002","journal-title":"J. Clin. Psychiatry"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:37:05Z","timestamp":1777613825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":235,"alternative-id":["10.3389\/fphar.2026.1806954"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1806954","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1806954"}}